A recent study showed that in severe COVID-19 patients, within 10 days of the onset of respiratory symptoms, splenic and lymph node germinal centers (GCs) and B cell lymphoma 6 (Bcl-6+) expressing B cells are markedly diminished. This evidence concerns the gene BCL6 and COVID-19.